MedTrace Logo

Angioplasty and Heart Stents to Treat Individuals With an Occluded Artery Following a Heart Attack

NCT00025766 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 380

Last updated 2013-11-27

No results posted yet for this study

Summary

The purpose of this study is to evaluate arterial patency and left ventricular ejection fraction by examining angiographic data one year following a heart attack and treatment with late revascularization.

Conditions

Interventions

DEVICE

PCI with stenting

PCI with stenting of the occluded culprit infarct-related artery

BEHAVIORAL

Optimal Medical Therapy

Participants will receive optimal medical therapy.

Sponsors & Collaborators

  • National Heart, Lung, and Blood Institute (NHLBI)

    collaborator NIH

  • University Health Network, Toronto

    lead OTHER

Principal Investigators

  • Vladimir Dzavik, MD · University Health Network - Toronto General Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2001-09-30
Primary Completion
2006-04-30
Completion
2011-12-31

Countries

  • Canada

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00025766 on ClinicalTrials.gov